Predictive factors for residual disease in re-excision specimens after breast-conserving surgery

Breast Journal

Volumn 18, Issue 4, 2012, Pages 339-344

  Atalay, Can ^a   Irkkan, Cigdem ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

breast conserving surgery; positive margins; re excision specimen; residual disease

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PHYSICAL EXAMINATION; PREDICTION; REOPERATION; TUMOR VOLUME;

ADULT; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PATHOLOGY, SURGICAL; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 84863726187     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01249.x     Document Type: Article

References (25)

1. Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003; 97: 926-33.
2. Bani MR, Lux MP, Heusinger K, et al. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol 2009; 35: 32-7.
3. Tartter PI, Bleiweiss IJ, Levchenko S,. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 1997; 185: 268-73.
4. Mullenix PS, Cuadrado DG, Steele SR, et al. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy. Am J Surg 2004; 187: 643-6.
5. Voguet L, Hebert T, Leveque J, et al. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer. The Breast 2009; 18: 233-7.
6. Keskek M, Kothari M, Ardehali B, Betambeau N, Nasiri N, Gui GP,. Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol 2004; 30: 1058-64.
7. Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 2008; 15: 2542-9.
8. Dillon MF, Hill ADK, Quinn CM, McDermott EW, O'Higgins N,. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006; 13: 333-9.
9. Aziz D, Rawlinson E, Narod SA, et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 2006; 12: 331-7.
10. Chagpar AB, Martin RCG 2nd, Hagendoorn LJ, Chao C, McMasters KM,. Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg 2004; 188: 399-402.
11. Cellini C, Hollenbeck ST, Christos P, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol 2004; 11: 915-20.
12. Kouzminova NB, Aggarwal S, Aggarwal A, Allo MD, Lin AY,. Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer. Am J Surg 2009; 198: 771-80.
13. Jardines L, Fowble B, Schultz D, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery 1995; 118: 803-9.
14. Darvishian F, Hajdu SI, DeRisi DC,. Significance of linear extent of breast carcinoma at surgical margin. Ann Surg Oncol 2003; 10: 48-51.
15. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW,. Attaining negative margins in breast-conserving operations: is there a consensus among breast surgeons? J Am Coll Surg 2009; 209: 608-13.
16. Landheer MLEA, Klinkenbijl JHG, Pasker-de Jong PCM, Wobbes T,. Residual disease after excision of non-palpable breast tumours: analysis of tumour characteristics. Eur J Surg Oncol 2004; 30: 824-8.
17. Caughran JL, Vicini FA, Kestin LL, Dekhne NS, Benitez PR, Goldstein NS,. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Ann Surg Oncol 2009; 16: 3020-7.
18. Miller AR, Brandao G, Prihoda TJ, Hill C, Cruz AB Jr, Yeh IT,. Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol 2004; 86: 134-40.
19. Tengher-Barna I, Hequet D, Reboul-Marty J, et al. Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol 2009; 22: 299-305.
20. Pittinger TP, Maronian NC, Poulter CA, Peacock JL,. Importance of margin status in outcome of breast-conserving surgery for carcinoma. Surgery 1994; 116: 605-8.
21. Skripenova S, Layfield LJ,. Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens. Arch Pathol Lab Med 2010; 134: 109-14.
22. Sabel MS, Rogers K, Griffith K, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol 2009; 99: 99-103.
23. van der Velden APS, van de Vrande SLB, Boetes C, Bult P, Wobbes T,. Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: the effect of time. J Surg Oncol 2007; 96: 569-74.
24. Schiller DE, Le LW, Cho BCJ, Youngson BJ, McCready DR,. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol 2008; 15: 833-42.
25. Lovricks PJ, Cornacchi SD, Farrokhyar F, et al. The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer. Am J Surg 2009; 197: 740-6.